# <font color='navy'><center>  pan-Cancer project</font>  
  
## <font color='darkgreen'> HER2 prediction </font>

The triple negative breast cancer is considered as the most maglinancy cancer type.   
    
To conduct evaluatation of immuno therapy, we first collect hundrands of breast cancer sample with survival infomation and Gene Expression Matrix.  
   
However, only part of the samples are labeled with 'HER2' status which is one of the three biomarker to distinguish triple-negative breast cancer from its analogy.